Anti-DNA antibodies and antibodies against DNA-associated proteins;Anticuerpos anti-ADN y dirigidos contra proteinas asociadas al ADN

Revista Espanola de Reumatologia

Volumn 23, Issue 9, 1996, Pages 375-383

  Mahou, Margarita Rodríguez ^a   Sabaté, Elena Sánchez ^a   González, Carlos Manuel ^a   López Longo, Francisco Javier ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; DNA ANTIBODY; DNA TOPOISOMERASE; HISTONE ANTIBODY;

AUTOIMMUNITY; HUMAN; REVIEW; SYNDROME CREST; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS;

EID: 12644296021     PISSN: 03044815     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (104)

1. Alberts B. Bray O. Lewis J, Raff M. Roberts K. Watson JD, editores. Molecular biology of the cell Nueva York?? Garland Publishing Inc., 1983.
2. Raptis L. Ménarcl HA. Quantitation and characterization of plasma DNA in normals and patients with systemic lupus erythematosus, J Clin Invest 1980; 66: 1 391-1.399.
3. Koffler D. Miller TE. Faiferman I. Antipolynucleotide antibodies, the rheumatic connection Human Pathol 1983: 14: 406-418.
4. Arana R, Seligman M Antibodies to native and denatured deoxynbonucleic acid in systemic lupus erv thematosus. J Clin Invest 1967. 46 1 867-1 882
5. Gilliam AC Long D LospallutoJJ Antibodies to double stranded-deoxyribonucleic acid, purification and characterization of binding specificities J Immunol 1980, 125 874-885.
6. Stollar BD Antibodies to DNA CRC Crit Rev Biochem 1986: 20 1-36
7. Schoenfeld Y, Rauch J, .Massicote H et al Polyspecificity of monoclonal lupus autoantibodies produced by human-human hybridomas X Engl J Med 1983, 308 414-420
8. Schwartz. RS, Stollar BD Origins of anti-DNA uutoantiboclies. J Clin Invest 1985 75 321-327
9. Isenberg DA, Schoenfeld Y, Schwartz RS Multiple serologic reactions and their relationship to clinical activity in systemic lupus erythematosus. Arthritis Rheum 1984, 27. 132-138
10. Lafer EM, Rauch J Andrzejewski JR et al Polyspecific monoclonal lupus autoantibodies reactive with both polynucleotides and phospholipids J Exp Med 1981. 153 897-909
11. Zhang W, Reichlin M IgM anti-A and D snRNP proteins and IgM anti-dsDNA are closely associated in systemic lupus erythematosus Clin Immunol Immunopathol 1995, 74: 7076
12. Puccetti A, Madaio MP, Bellese G. Mighorini P. Anti-DNA antibodies bind to DNase I J Exp Med 1995. 181: 1 797-1.804.
13. Zack DJ, Yamamoto K, Wong AL. Stempmak M. French C. Weisbart RH. DXA munies a self-protein that may be a target for some anti-DNA antibodies in systemic lupus erythematosus.J Immunol 1995. 154 1 987-1. 994
14. Rekvig OP. Fredricksen K. Hokland K et al Molecular analysis of anti-DNA antibodies induced by polyomavirus UK in BALB, c mice, Scand J Immunol 1995, 41 593-602
15. Marchini B. Puccetti A, Dolcher MP, Madaio MP, Mighorini P Induction of anti-DXA antibodies in non autommune mice by immunization with a DXA-DNAase 1 complex- Clin Exp Rheumatol 1995, 7-10
16. Gilbert D. Margaritte C, Payelle-Brogan B. Tion F. Development of the B cell anti-DNA repertorre in (NZBX NZW) F1 mice Relationship with the natural autoimmune repertorre J Immunol 1992. 149 1.795-1 801.
17. Foster MH. Madaio MP. Barrett KJ Variable region sequence analysis of anti-DNA antibodies evidence foi a family of closely related getme-line VH genes encoding lupus autoantibodies. DNA Cell Biol 1992. 11 175-182
18. Taki S. Hirose S Kinoshita K et al. Somatically mutated IgG anti-DNA antibody clonally related to germ-line encoded IgM anti-DNA antibody Eur J Immunol 1992, 22. 987-992
19. Livneh A Oi G, Many A, Gazit E. Diamond B Anti-DNA antibodies secreted by peripheral B cells of lupus patients have both normal and lupus specific features Clin Immunol Immunopathol 1993. 68 68-73
20. Ehrenstein MR. Hartley B. Wilkinson LS. Isenberg DA Comparison of monoclonal and polyclonal anti-idiotype against a human IgG anti-DNA antibody J Autoimmun 1994, 349-367.
21. Smeenk R, Van der Lilij G, Aarden L Merasurement of low avidity anti-dsDNA by the Crithidia luciliae test and the PEG assay. Clin Exp Immunol 1982, 50. 603-610
22. Aarden LA. Lakmaker F, De Groot ER. Felikamp TEW Immunology of DNA III Crithidia luciliae a simple substrate for the determination of anti-ds DNA with the immunofluorescence technique Ann XY Acad -Sci 1975. 254 505-515
23. Isenberg DA Dudeney C. Williams W et al Measurement of anti-DNA antibodies: a reappraisal using five different methods. Ann Rheum Dis 1987; 46: 448-456
24. Jensen EM. Deng JS, Beutner EH. Kumar V. Chorzelski TP Comparison of commercial kits for the detection of anti-native DNA antibodies using Crithidia luciliae Am J Clin Pathol 1987; 87: 461-469
25. McGuigan L, Edmonds J. Wellings G. Jones M. The Significance of discrepant Farr and Crithidia luciliace tests. J Rheumatol 1984, 11: 172-174
26. Eilat D. Anti-DNA antibodies: problems in their study and interpretation. Clin Exp Immunol 1986; 65 215-222
27. Tan EM. Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology Adv Immunol 1989; 44: 93-151
28. Tan EM, Robinson CA, Nakamura RM Antinuclear antibodies in systemic rheumatic disease. Postgr Med 1985; 78: 141-148
29. Froelich CJ, Wallman J, Skosey JL, Teodorescu M Clinical value of an integrated ELISA system for the detection of 6 auto-antibodies Lss DNA. els DNA. Sm, RNP/Sm. SSA and SSB). J Rheumatol 1990; 17: 192-200.
30. Swaak T, Smeenk R Detection of anti-dsDNA as a diagnostic tool: a prospective study in 441 non-systemic lupus erythematosus with anti-dsDNA antibodies. Ann Rheum Dis 1985; 44: 245-251
31. Smeenk R, Westgeest T, Swaak T. Antinuclear antibodies determination, the present state of diagnostic and clinical relevance. Scand J Rheumatol 1985, 56: (.Supl) 78-92.
32. Juby A, Johnston C, Davis P Specificity, sensitivity and diagnostic predictive value of selected laboratory generated auto-antibodies profiles in patients with connective tissue diseases J Rheumatol 1991; 18: 354-358.
33. Nossent JC, Huysen V, Smeenk RJT, Swaak AJG Low avidity antibodies to dsDNA in systemic lupus erythematosus a longitudinal study of their clinical significance. Ann Rheum Dis 1989; 48: 677-682
34. Thompson D, Juby A, Davis P The clinical significance of autoantibody profiles in patients with systemic lupus erythematosus. Lupus 1993; 2: 15-19
35. Appel AE Sablay LB, Golden RA, Barland P, Grayzel AI, Bank N. The effect of normalization of serum complement and anti-DNA antibody on the course of lupus nephritis: correlation with seventy of renal histology Am J Med 1978; 64: 274-283.
36. Okamura M, Kanayama Y, Amastu K et al Significance of enzyme-linked immunosorbent assay (ELISA) for antibodies to double stranded and single stranded DNA in patients with lupus nephritis: correlation with severity of renal histology. Ann Rheum Das 1993; 52: 14-20
37. Morillas L, Gömez-Reino J, Ibero I et al Manifestaciones neurológicas en lupus eritematoso sistémico Análisis de 22 pacientes. Rev Clin Esp 1985; 176: 26-31.
38. Swaak AJG, Groenwold J, Bronsveld W Predictive value of complement profiles and anti-dsDNA in systemic lupus erythematosus. Ann Rheum Dis 1986; 45: 359-366
39. Ter Borg EJ, Horst G, Hummel EJ, Limburg PC, Kallenberg CGM Measurement of increased anti-ds DNA antibody levels as a predictor of disease exacerbations in systemic lupus erythematosus Arthritis Rheum 1990; 33: 634-643
40. Sasaki T, Muryoi T, Hatakeyama A et al. Circulating anti-DNA immune complexes in active lupus nephritis Am J Med 1991; 91: 355-362
41. Monoka T, Woitas R, Fujigaki Y, Batsford SR, Vogt A. Histone mediates glomerular deposition of small size DNA: anti-DNA complex Kidney Int 1994; 45: 991-997
42. Izui S, Lambert PH, Miesher PA. Failure to detect circulating DNA, anti-DNA complexes in systemic lupus erythematosus Clm Exp Immunol 1977; 30: 184-192
43. Izui S, Lambert PH, Miesher PA In vitro demonstration of a paiticular affinity ol glomerular basement membrane and collagen for DNA: a possible basis for a local formation of DNA anti-DNA complexes in systemic lupus erythematosus J Exp Med 1970; 144: 428-443.
44. Hylkema MN, Zwet IV Kramers C et al No evidence for an independent role of anti-heparan sulphate reactivity apart from anti-DNA in lupus nephritis. Clin Exp Immunol 1995, 101: 55-59
45. McGhee JD, Felsenfeld G. Nucleosome structure. Ann Rev Biodem 1980; 49: 1.115-1.156.
46. Fritzler MJ, Tan EM. Antibodies to histories in drug-induced and idiopathic lupus erythematosus. J Clin Invest 1978; 62: 560-567.
47. Rubin RL, Joslin FG. Tan EM. Specificity of antihistone antibodies in systemic lupus erythematosus. Arthritis Rheum 1982; 25: 779-782.
48. Hardin JA, Thomas JO Antibodies to histones in systemic lupus erythematosus: localization and prominent autoantigens on histones H1 and H2B Proc Natl Acad Sci USA 1983, 80: 7.410-7 414
49. Cohen MG. Webb J Anti-histone antibodies in rheumatoid arthritis and Felty's syndrome Arthritis Rheum 1989; 32 1 319-1-324.
50. Portanova JP, Arndt RE, Tan EM, Kotzin BL Anti-histone antibodies in idiopathic and drug-induced lupus recognize distinct intrahistone regions. J Immunol 1987; 138; 446-451
51. Gohill J, Cary PD, Couppez M, Fritzler MJ. Antibodies from patients with drug-induced and idiopathic lupus erythematosus react with epitopes, restricted to the amino and carboxyl termini of histones. J Immunol 1985, 135: 3 116-3.121
52. Gioud M, Aitkaci M, Monier JC Histone antibodies in systemic lupus erythematosus. A possible diagnostic tool Arthritis Rheum 1982, 25: 407-413.
53. Costa O, Monier JC. Antihistone antibodies detected by ELISA and immnunoblotting in systemic lupus erythematosus and rheumatoid arthritis J Rheumatol 1986; 13 722-725.
54. Epstein A, Greenberg M, Halbert S. Kramer L, Borland P The clinical application of an ELISA technique for the detection of antihistone antibodies. J Rheumatol 1986; 13 304-307.
55. Portanova JP. Rubin JL. Joslin FG, Agnello VD, Tan EM. Reactivity of antihistone antibodies induced by procainamide and hydralazine. Clin Immunol Immunopathol 1982; 25: 6779.
56. Totoritis MC, Tan EM, Mcnally EM, Rubin RL Association of antibody to histone complex H2A-H2B with symptomatic procainamide-induced lupus. N Engl J Med 1988; 318: 141-143
57. Meyer O. Cyna L, Haim T. Ryckewaert A Les anticorps antihistones de type IgG valeur diagnostique au cours de la polyarthrite rheumatoicle, de Li scléroctermie, de la maladie lupique spontanée et médicamenteuse. Rev Rhum 1984; 51. 303-310.
58. Krippner H, Springer B, Merle S. Pirlet K Antibodies to histones of the IgG and IgM class in systemic lupus erythematosus Clin Exp Immunol 1984; 58 49-56
59. García de la Torre I, Miranda-Méndez L Studies of antinuclear antibodies in rheumatoid arthritis. J Rheumatol 1982; 9 603-606.
60. Malleson P. Petty RE, Fung M, Candido EPM. Reactivity of antinuclear antibodies with histones and other antigens in juvenile rheumatoid arthritis Arthritis Rheum 1989; 32 919923
61. Ostensen M, Fredriksen K, Kass E, Rekvig OP. Identification of antihistone antibodies in subsets of juvenile chronic arthritis. Ann Rheum Dis 1989, 48. 114-117.
62. Stemmer C, Tuaillon N, Prieur AM, Muller S. Mapping of Bcell epitopes recognized by antibodies to histones in subsets of juvenile chronic arthntis. Clin Immunol Immunopathol 1995; 76. 82-89
63. Sato S, Ihn H, Sonia Y et al. Antihistone antibodies in patients with localized scleroderma. Arthritis Rheum 1993, 36 1 137-1 141.
64. Sato S. Ihn H, Kijuchi K, Takehara K. Antihistone antibodies in systemic sclerosis. Association with pulmonary fibrosis. Arthritis Rheum 1994, 37: 391-394.
65. Bernstein RM. Hobbs RN. Lea DJ, Vard DJ, Hughes GRV Patterns of antihistone antibody specificity in systemic rheumatic disease I Systemic lupus erythematosus, mixed connective e tissue disease, primary sicca syndrome and rheumatoid arthritis With vasculitis Arthritis Rheum 1985; 28 285-293.
66. Fritzler MJ, Ryan P, Kinsella TD. Clinical features of systemic lupus erylhematosus patients with antihistone antibodies J Rheumatol 1982;9: 46-51.
67. De Rooij DJ, Van de Putte LB, Habets WJ, Verbee KAL, Van Venrooij WJ. The use of immunoblotting to detect antibodies to nuclear and cytoplasmic antigens Scand J Rheumatol 1988; 17: 353-364
68. Chou MJ, Lee SL, Chen TY. Tsay CJ. Specificity of antinuclear antibodies in primary biliary cirrhosis Ann Rheum Dis 1995; 54: 148-151.
69. Douvas AS. Achten M, Tan EM. identification of a nuclear protein (Scl-70) as a aunique target of human antinuclear antibodies in scleroderma J Biol Chem 1979, 254: 10.514-10.522.
70. Van Venrooij WJ, Stapel SO, Houben H et al. Sel-86, a marker antigen for diffuse scleroderma J Clin Invest 1985; 75: 1.053-1.060.
71. Maul GG. French BT, Van Venrooij WJ, Jiméncz SA. Topoisomerase I identified by scleroderma 70 sera, enrichment of topoisomerase I at the centromere in mouse mitotic cells before anaphase. Proc Natl Acad Sci USA 1986; 83 5.145-5 149
72. Shero JH, Bordwell B, Rothfield NF, Earnshaw WC. Highs titers of autoantibodies to topoisomerase I (Scl-70) in sera from scleroderma patients. Science 1986; 231: 737-740.
73. Verheijen R, Van den Hoogen \'D, Brijer R et al. A recombinant topoisomerase I used for autoaitibody detection in sera from patients with systemic sclerosis. Clin Exp Immunol 1990; 80: 38-43.
74. Kuwana M, Kaburaki J, Mimori R, Tojo T, Homma M. Autoantigenic epitopes on DNA topoisomerase I Clinical and immunogenetic associations in systemic sclerosis Arthritis Rheum 1993; 36 1 406-1 413
75. Aeschlimann A. Meyer O, Bourgeois P et al. Anti-Scl 70 antibodies detected by immunoblotting in progressive systemic sclerosis specificity and clinical correlations Ann Rheum Dis 1989; 48: 992-997
76. Hildebrandt S. Weiner ES, Senecal JL, Noell GS, Earnshaw WC, Rothfield N. Autoantibodies to topoisomerase I (Scl 70) analysis by gel diffusion, immunoblot and enzyme-linke immunosorbent assay. Clin Immunol Immunopathol 1990, 57: 399-410.
77. Weiner ES, Hildebrandt S, Senecal JL et al Prognostic significance of anticentromere antibodies and anti-topoisomerase I antibodies in Raynaud's disease. Arthritis Rheum 1991: 34: 68-77
78. Firtzler MJ, Kinsella TE. Garbutt E The CREST syndrome: a distinct serologie entity with anticentromere antibodies. Am J Med 1980; 69 520-526.
79. Kuwana M, Kaburaki J, Okano Y, Tojo T, Homma M Clinical and prognostic associations based on serum antinuclear antibodies in Japanese patients with systemic sclerosis Arthritis Rheum 1994: 37. 75-83.
80. Verheijen R, De Jong BAW, Van Venrooij WJ A recombinant topoisomerase I ELISA: screening for IgG, IgM and IgA antitopoisomerase I autoantibodies in human sera Clin Exp Immunol 1992, 89: 456-460
81. McNeilage LJ, Youngchaiyud V, Whittmgham S Racial differences in antinuclear antibody patterns and clinical manifestations of scleroderma. Arthritis Rheum 1989, 32. 54-60
82. Takehara K. Moroi Y. Ishibashi Y Antinuclear antibodies in the relatives of patients with systemic sclerosis Br J Dermatol 1985, 112 23-33.
83. Kallenberg CGM. Wouda AA, Hoet MH, Van Venrooij WJB. Development of connective tissue diseases in patients presenting with Raynaud's phenomenon, a six year follow-up wnh emphasis on the predictive value of antinuclear antibodies as detected by immunoblottmg. Ann Rheum Dis 1988; 47: 634-641
84. Genth E. Mierau R, Genetzky P et al Immunogenetic associations of scleroderma-related antinuclear antibodies. Arthritis Rheum 1990. 33. 657-665
85. Briggs DC, Vaughan RW, Welsh KI. Myers A, Dubois RM, Black CM Immunogenetic prediction of pulmonary fibrosis in systemic sclerosis. Lancet 1991, 338. 661-662
86. Reveille JD, Durban E, Goldstein R, Moreda R, Arnett FC. Racial differences in the frequencies of scleroderma-related autoantibodies Arthritis Rheum 1992; 35 216-218
87. Weiner ES. Earnshaw WC. Sénecal JL, Bordwell B, Johnson P, Rothfield NF. Clinical associations of anticentromere antibodies and antibodies to topoisomerase I: A study of 355 patients. Arthritis Rheum 1988; 31: 378-385.
88. Moroi Y, Peebles C, Fritzler MJ. Steigerwald J, Tan EM. Autoantibody to centromere (Kinetochore) in scleroderma sera Proc Natl Acad Sci USA 1980; 77: 1 627-1 631
89. Earnshaw W, Bordwell B, Marino C, Rothfield N. Three human chromosomal autoantigens are recognized by sera from patients with anticentromere antibodies J Clin Invest 1986; 77: 426-430
90. Earnshaw WC, Sullivan KF, Machlin PS et al The major human centromere autoantigen J Cell Biol 1987; 104. 817-829
91. Sullivan KF, Hechenberger M, Masri K. Human CENP-A contains histone H3 related histone fold domain that is required for targeting to the centromere J Cell Biol 1994; 127: 581-587.
92. Muio Y, Sugimoto K, Okazaki T, Ohashi M. The heterogeneity of anticentromere antibodies in immunoblottmg analysis J Rheumatol 1990; 17. 1 042-1.047.
93. McHugh NJ, James IE, Maddison PJ Differential isotype recognition of two centromere associated polypepticles by immmioblotting in connective tissue disease. Clin Exp Immunol 1988. 72: 457-464
94. Rothfield N, Whitaker D, Bordwell B. Weiner E. Senecal JL. Earnshaw W Detection of anticentromere antibodies using cloned autoantigen CENP-B Arthritis Rheum 1987, 30: 1 416-1 419.
95. Chen Z, Federick JA, Pandey JP et al Anticentromere antibodies and immunoglobulin allotypes in scleroderma. Arch Dermatol 1985; 121: 339-344
96. Goldman JA. Anticentromere antibodies in patients without CREST and scleroderma association with active digital vasculitis in rheumatic and connective tissue disease. Ann Rheum Dis 1989, 48: 771-775
97. .McCarty GA, Rice JR. Bembe ML, Barada FA. Anticentromere antibody clinical correlations and association with favourable prognosis in patients with scleroderma variants Arthritis Rheum 1983; 26: 1-7
98. Picillo V, Migharesi S, Vatti M, Marciales MR, Ferruzzi AM, Tirri G Demographic differences in the frequencies of scleroderma-related autoantibodies. Arthritis Rheum 1993; 36. 1.332-1.333.
99. Mimori T, Akizuki M, Yamagata H, Imada S. Yoshida S, Homma M. Characterization of a high molecular weight acidic nuclear protein recognized by autoantibodies in sera from patients with polymyositis-scleroderma overlap J Clin Invest 1981; 68 611-620
100. Yaneva M, Arnett FC Antibodies against Ku protein in sera from patients with autoimmune diseases Clin Exp Immunol 1989. 76: 366-372.
101. Hirakata H, Mimori T, Akizuki M, Craft J, Hardin JA. Homma M Autoantibodies to small nuclear and cytoplasmic ribonucleoproteins in Japanese patients with inflammatory muscle disease Arthritis Rheum 1992; 35 449-456
102. Reeves WH Use of monoclonal antibodies for the characterization of novel DNA-binding proteins recognized by human autoimmune sera. J Exp Med 1985; 161. 18-39
103. Nikaido T, Shimada K. Shibata M et al. Cloning and nucleotide sequence of cDNA for Ki antigen, a highly conserved nuclear protein detected with serum from patients with systemic lupus erythematosus Clin Exp Immunol 1990, 79. 209-214
104. Sakamato M, Takasaky Y. Yamanaka K et al Purification and characterization of Ki antigen and detection of anti-Ki antibodies by enzyme-linked immunosorbent assay in patients, with systemic lupus erythematosus Arthritis Rheum 1989: 32 1.554-1.558